[Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective].
Santos-Preciado
José Ignacio
JI
Hospital Infantil de México, Federico Gómez. jisantos@himfg.com.mx
Franco-Paredes
Carlos
C
D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D019090:Case Management; D015897:Comorbidity; D003906:Developing Countries; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D024901:Drug Resistance, Multiple, Bacterial; D014943:Global Health; D015658:HIV Infections / Q000453:epidemiology; D006801:Humans; D007390:International Agencies; D008800:Mexico / Q000453:epidemiology; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D013997:Time Factors; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D014944:World Health Organization
D000995:Antitubercular Agents